A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer
Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the overall response rate, toxicity, progression
free survival and quality of life of chemotherapy with docetaxel and oxaliplatin in recurrent
or metastatic breast cancer.